I am more of a fundamental data and momentum trader and less of a chart technician. That's why I wouldn't touch any of these stocks at the moment. They all have such a low RSI for a reason. All of them have recently disappointed on one or more occasions. Forecasts have been missed. And I generally do not invest in such stocks because, unless there are one-off special effects, there are structural problems or poor management is at the helm. I see the former at $ZTS, $FI and $NOVO B, while $CMG has only gone downhill since the change of management. I have not looked at the other three, as their business model alone means that they are not investment cases for me.
Of course, $NOVO B, for example, could go up 15-25% again. However, I don't see the time to trade on it in the current market environment. In my opinion, $NOVO B will have a difficult time in the long term. They have a medical business with diabetes. This is huge, but also highly competitive and margins are falling rapidly.
Of course, $NOVO B, for example, could go up 15-25% again. However, I don't see the time to trade on it in the current market environment. In my opinion, $NOVO B will have a difficult time in the long term. They have a medical business with diabetes. This is huge, but also highly competitive and margins are falling rapidly.
•
22
•
@Multibagger Solid answer 😁
•
11
•@BamBamInvest have made an effort.😉
•
11
•